Table 3.
Asthma-related adverse events, asthma-related serious adverse events, and courses of oral corticosteroids
| UC + BrEX |
UC |
|||||||
|---|---|---|---|---|---|---|---|---|
| Number of Participants | Number of Events | Number of Participants | Number of Events | IRR* | P Value | |||
| Adverse events | — | — | — | — | — | — | 1.47 | 0.381 |
| 0 | 80 | (85.1%) | 0 | 81 | (81.8%) | 0 | — | — |
| 1 | 11 | (11.7%) | 11 | 12 | (12.1%) | 12 | — | — |
| 2 | 1 | (1.1%) | 2 | 3 | (3.0%) | 6 | — | — |
| 3+ | 2 | (2.1%) | 21 | 3 | (3.0%) | 21 | — | — |
| Total | 94 | (100%) | 34 | 99 | (100%) | 39 | — | — |
| Serious adverse events | — | — | — | — | — | — | 2.03 | 0.159 |
| 0 | 88 | (93.6%) | 0 | 90 | (90.9%) | 0 | — | — |
| 1 | 6 | (6.4%) | 6 | 6 | (6.1%) | 6 | — | — |
| 2 | 0 | (0%) | 0 | 3 | (3.0%) | 6 | — | — |
| Deaths | 0 | (0%) | 0 | 0 | (0%) | 0 | — | — |
| Total | 94 | (100%) | 6 | 99 | (100%) | 12 | — | — |
| OCS courses† | — | — | — | — | — | — | 0.82 | 0.704 |
| 0 | 87 | (92.6%) | 0 | 93 | (94.9%) | 0 | — | — |
| 1 | 6 | (6.4%) | 6 | 3 | (3.1%) | 3 | — | — |
| 2 | 1 | (1.1%) | 2 | 2 | (2.0%) | 4 | — | — |
| Total | 94 | (100%) | 8 | 98 | (100%) | 7 | — | — |
Definition of abbreviations: IRR = incidence rate ratio; OCS = oral corticosteroids; UC = usual care alone; UC+BrEX = breathing exercises and usual care.
*
UC group compared with UC + BrEX group.
†
One missing in UC group.